Argenx Se (ARGX) Other Non Operating Income (2016 - 2026)
Argenx Se's (ARGX) quarterly Other Non Operating Income came in at -$8.0 million in Q2 2026, down 116.47% on a YoY basis from $48.6 million in Q2 2025, and up 27.27% quarter-over-quarter from -$11.0 million in Q1 2026.
Powered by 
Analysis
Argenx Se (ARGX) Other Non Operating Income (2016 - 2026) Analysis & Trends
Argenx Se (ARGX) has reported Other Non Operating Income for 11 consecutive years, with -$8.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non Operating Income fell 116.47% year-over-year to -$8.0 million; the trailing twelve-month figure through Jun 2026 stood at -$29.2 million (down 153.53% YoY), and the FY2025 full-year result was $65.8 million, up 236.47% from the prior year.
- Other Non Operating Income grew to -$8.0 million in Q2 2026 per ARGX's latest filing, from -$11.0 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $60.3 million in Q4 2022 and bottomed at -$54.9 million in Q4 2024.
- Historically, Other Non Operating Income has averaged -$1.1 million across 5 years, with a median of -$7.6 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income plunged 542.15% in 2022, then surged 714.51% in 2025.
- Over 5 years, Other Non Operating Income stood at $60.3 million in 2022, then sank by 37.9% to $37.4 million in 2023, then sank by 246.78% to -$54.9 million in 2024, then soared by 84.77% to -$8.4 million in 2025, then grew by 4.34% to -$8.0 million in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$8.0 million, -$11.0 million, and -$8.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Argenx Se | 58.53 Bn | 53.35 Bn | 1.37 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.00 Mn |
| Mar 31, 2026 | -11.00 Mn |
| Dec 31, 2025 | -8.36 Mn |
| Sep 30, 2025 | -1.85 Mn |
| Jun 30, 2025 | 48.57 Mn |
| Mar 31, 2025 | 27.00 Mn |
| Dec 31, 2024 | -54.92 Mn |
| Sep 30, 2024 | 33.93 Mn |
| Jun 30, 2024 | -7.90 Mn |
| Mar 31, 2024 | -19.31 Mn |
| Dec 31, 2023 | 37.42 Mn |
| Sep 30, 2023 | -32.51 Mn |
| Jun 30, 2023 | -2.00 Mn |
| Mar 31, 2023 | 11.17 Mn |
| Dec 31, 2022 | 60.26 Mn |
| Sep 30, 2022 | -39.61 Mn |
| Jun 30, 2022 | -46.17 Mn |
| Mar 31, 2022 | -7.21 Mn |
| Dec 31, 2021 | -14.06 Mn |
| Sep 30, 2021 | -17.62 Mn |
API Access
Argenx Se Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ARGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "ARGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ARGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();